NantHealth, Inc. (NASDAQ-GS: NH), proudly announces the expansion of its product leadership team by appointing three seasoned executives who will spearhead efforts to integrate innovation, automation, and artificial intelligence into the company's product offerings. This strategic move underscores NantHealth's unwavering commitment to revolutionizing healthcare technology and delivering excellence to its customers.

Keith Krebs - Senior Vice President and General Manager, Eviti

Keith Krebs is appointed as the Senior Vice President and General Manager for the Eviti Connect product line, bringing a wealth of experience in driving innovation and customer satisfaction. With a remarkable track record in leadership roles spanning implementations, client services and product development, Krebs is poised to lead the charge in leveraging artificial intelligence and automation to enhance the Eviti platform's capabilities.

Sean Henson - Senior Vice President and General Manager, NaviNet

Sean Henson assumes the role of Senior Vice President and General Manager for NaviNet a leading payer-provider collaboration platform, facilitating provider engagement and generating actionable data throughout the continuum of care delivery. With over a decade of expertise in value-based care performance and analytics, Henson is committed to leveraging advanced technologies to optimize patient care quality and cost-effectiveness within the NaviNet platform.

Alan Brown - Senior Vice President and General Manager, OpenNMS

Alan Brown joins NantHealth as the Senior Vice President and General Manager of the OpenNMS product line, responsible for overseeing the world's first full open-source enterprise-grade network service monitoring. With over 30 years of experience in Aerospace & Defense and Telecommunication industries, Brown is dedicated to driving innovation and efficiency through strategic business vision and results-driven tactical execution.

NantHealth's recent appointments emphasize the company's strategic commitment to integrating innovation, automation, and artificial intelligence into its product development process. With a leadership team that possesses a deep understanding of industry dynamics and a strong drive to effect positive change, NantHealth is well-positioned to consistently deliver cutting-edge products and services that cater to the evolving needs of its customers.

“We are excited to welcome Keith, Sean, and Alan to our leadership team,” said Lauren Schiegg, Chief Operating Officer at NantHealth. “Their extensive experience and visionary leadership will play a crucial role in accelerating our efforts to innovate and drive positive transformation in the healthcare technology landscape. Together, we are committed to delivering unparalleled value to our customers and revolutionizing healthcare for the better.”

About NantHealth, Inc.

NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealth’s product portfolio comprises the latest technology in payer-provider collaboration platforms for real-time coverage, decision support and data solutions that provide multi-data analysis, reporting and professional services offerings. For more information, visit, follow us on Twitter, Facebook, LinkedIn and YouTube and subscribe to our blog.

Forward Looking Statements

This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to, statements regarding the timing and effectiveness of the reverse stock split and the Company’s ability to maintain its listing on Nasdaq (including its ability to achieve or maintain the minimum bid price required by Nasdaq and to comply with other requirements for listing on Nasdaq). Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current plans, objectives, beliefs, expectations, and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the price and volume fluctuations in trading of the Company’s Common Stock, the potential adverse effect of the reduced number of shares outstanding following the reverse stock split on the liquidity of the Company’s Common Stock, potentially adverse Nasdaq decisions related to the listing of the Company’s Common Stock on the Nasdaq Capital Market. The Company undertakes no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.

Jen Hodson NantWorks 562-397-3639

NantHealth (NASDAQ:NH)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more NantHealth Charts.
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more NantHealth Charts.